Cargando…
An intellectual-disability-associated mutation of the transcriptional regulator NACC1 impairs glutamatergic neurotransmission
Advances in genome sequencing technologies have favored the identification of rare de novo mutations linked to neurological disorders in humans. Recently, a de novo autosomal dominant mutation in NACC1 was identified (NM_052876.3: c.892C > T, NP_443108.1; p.Arg298Trp), associated with severe neur...
Autores principales: | Daniel, James A., Elizarova, Sofia, Shaib, Ali H., Chouaib, Abed A., Magnussen, Helge M., Wang, Jianlong, Brose, Nils, Rhee, JeongSeop, Tirard, Marilyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393139/ https://www.ncbi.nlm.nih.gov/pubmed/37533751 http://dx.doi.org/10.3389/fnmol.2023.1115880 |
Ejemplares similares
-
A fluorescent nanosensor paint detects dopamine release at axonal varicosities with high spatiotemporal resolution
por: Elizarova, Sofia, et al.
Publicado: (2022) -
Targeted sensors for glutamatergic neurotransmission
por: Hao, Yuchen, et al.
Publicado: (2023) -
Effects of Psychotherapy on Glutamatergic Neurotransmission
por: Wade-Bohleber, Laura, et al.
Publicado: (2023) -
Changes in glutamatergic neurotransmission within the migraine cycle
por: Cosentino, G, et al.
Publicado: (2013) -
Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission
por: Montanari, Martina, et al.
Publicado: (2022)